AstraZeneca

News

Europe's CHMP recommends AZ's Forxiga in type 1 diabetes

The European Medicines Agency’s CHMP regulatory committee has recommended AstraZeneca’s Forxiga to help adults with type 1 diabetes manage their blood sugar.

News

Sobi buys AstraZeneca's RSV virus drug for $1.5bn

Sobi has completed the acquisition of AstraZeneca’s Synagis (palivizumab) for $1.5 billion in cash and shares, plus certain conditional payments.

Views & Analysis

Women in Science: AstraZeneca

We speak to three of AstraZeneca’s senior leaders about their careers, the future of their therapy areas and how the industry can encourage and support more women to purs

News

AZ's chief medical officer Bohen quits after shake-up

AstraZeneca’s chief medical officer Sean Bohen is to leave the company following its organisational shake-up.

News

AZ appoints controversial doctor to lead new oncology unit

AstraZeneca has a new and controversial oncology head after the departure of two key leaders led to a management reshuffle.

News

NICE broadens approval for AstraZeneca’s severe asthma drug

AstraZeneca’s Fasenra (benralizumab) has seen its fortunes reverse after NICE approved the drug for severe eosinophilic asthma – broadening its recommendations for the drug’s use and giving

Europe's CHMP recommends AZ's Forxiga in type 1 diabetes

Sobi buys AstraZeneca's RSV virus drug for $1.5bn

Women in Science: AstraZeneca

AZ's chief medical officer Bohen quits after shake-up

AZ appoints controversial doctor to lead new oncology unit

NICE broadens approval for AstraZeneca’s severe asthma drug

CMS aims for broader GLP-1 access via federal programmes

How to meet your physicians where they are online

AstraZeneca

Editor's Picks